Cargando…
USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ
Mutations and altered expression of deubiquitinating enzymes (DUBs) profoundly influence tumor progression. Ubiquitin-specific protease 1 (USP1) is a well-characterized human DUB reportedly overexpressed in and associated with maintaining the mesenchymal stem cell status of osteosarcoma (OS); howeve...
Autores principales: | Yuan, Putao, Feng, Zhenhua, Huang, Hai, Wang, Gangliang, Chen, Zhijun, Xu, Guang, Xie, Ziang, Jie, Zhiwei, Zhao, Xiangde, Ma, Qingliang, Wang, Shiyu, Shen, Yang, Huang, Yizhen, Han, Ying, Ye, Huali, Wang, Jiying, Shi, Peihua, Sun, Xuewu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134912/ https://www.ncbi.nlm.nih.gov/pubmed/35637948 http://dx.doi.org/10.7150/ijbs.65428 |
Ejemplares similares
-
ML264 inhibits osteosarcoma growth and metastasis via inhibition of JAK2/STAT3 and WNT/β‐catenin signalling pathways
por: Huang, Hai, et al.
Publicado: (2020) -
DUSP6 expression is associated with osteoporosis through the regulation of osteoclast differentiation via ERK2/Smad2 signaling
por: Zhang, Boya, et al.
Publicado: (2021) -
USP7 Inhibits Osteoclastogenesis via Dual Effects of Attenuating TRAF6/TAK1 Axis and Stimulating STING Signaling
por: Xie, Ziang, et al.
Publicado: (2023) -
The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling
por: Sun, Xuewu, et al.
Publicado: (2019) -
Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway
por: Jie, Zhiwei, et al.
Publicado: (2022)